Subgroup studies revealed that both FGF21 and ANGPTL8 had stronger and more consistent correlations with the presence and progression of NAFLD than RBP4 and LECT2, which had weaker or population-dependent effects. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.